Carla V. Finkielstein

Carla V. Finkielstein

Auto-generated profile, based on publicly available information

Carla V. Finkielstein

Fralin Biomedical Research Institute at Virginia Tech, Roanoke, VA, USA

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2004 in Cell
Verified
Journal Article
Closed access
DGDahai Gai
Dahai Gai
RZRui Zhao
Rui Zhao
DLDawei Li
Dawei Li
CFCarla V. Finkielstein
Carla V. Finkielstein
XCXiaojiang S. Chen
Xiaojiang S. Chen

16 October 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
IAI. Aiello
I. Aiello
MFM. L. Mul Fedele
M. L. Mul Fedele
FRF. Román
F. Román
LMLuciano Marpegan
Luciano Marpegan
CCC. Caldart
C. Caldart
NPN. Paladino
N. Paladino
Circadian disruption negatively affects physiology, posing a global health threat that manifests in proliferative, metabolic, and immune diseases, among others. Because outputs of the circadian clock regulate daily fluctuations in the immune response, we determined whether circadian disruption results in tumor-associated immune cell remodeling, facilitating tumor growth. Our findings show that tumor growth rate increased and latency decreased under circadian disruption conditions compared to normal light-dark (LD) schedules in a murine melanoma model. Circadian disruption induced the loss or inversion of daily patterns of M1 (proinflammatory) and M2 (anti-inflammatory) macrophages and cytokine levels in spleen and tumor tissues. Circadian disruption also induced (i) deregulation of rhythmic expression of clock genes and (ii) of cyclin genes in the liver, (iii) increased CcnA2 levels in the tumor, and (iv) dampened expression of the cell cycle inhibitor p21WAF/CIP1, all of which contribute to a proliferative phenotype.

1 October 2002 in Nature
Verified
Journal Article
Closed access
PDF file
DCDaniel G. S. Capelluto
Daniel G. S. Capelluto
TKTatiana G. Kutateladze
Tatiana G. Kutateladze
RHRaymond Habas
Raymond Habas
CFCarla V. Finkielstein
Carla V. Finkielstein
XHXi He
Xi He
MOMichael Overduin
Michael Overduin

3 June 2021 in Viruses
Verified
Journal Article
Open access
PDF file
VCVictoria Callahan
Victoria Callahan
SHSeth Hawks
Seth Hawks
MCMatthew Crawford
Matthew Crawford
CWCaitlin Woodson
Caitlin Woodson
Holly MorrisonHolly Morrison
Holly Morrison
KKKylene Kehn-Hall
Kylene Kehn-Hall
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible RNA virus that is the causative agent of the Coronavirus disease 2019 (COVID-19) pandemic. Patients with severe COVID-19 may develop acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) and require mechanical ventilation. Key features of SARS-CoV-2 induced pulmonary complications include an overexpression of pro-inflammatory chemokines and cytokines that contribute to a ‘cytokine storm.’ In the current study an inflammatory state in Calu-3 human lung epithelial cells was characterized in which significantly elevated transcripts of the immunostimulatory chemokines CXCL9, CXCL10, and CXCL11 were present. Additionally, an increase in gene expression of the cytokines IL-6, TNFα, and IFN-γ was observed. The transcription of CXCL9, CXCL10, IL-6, and IFN-γ was also induced in the lungs of human transgenic angiotensin converting enzyme 2 (ACE2) mice infected with SARS-CoV-2. To elucidate cell signaling pathways responsible for chemokine upregulation in SARS-CoV-2 infected cells, small molecule inhibitors targeting key signaling kinases were used. The induction of CXCL9, CXCL10, and CXCL11 gene expression in response to SARS-CoV-2 infection was markedly reduced by treatment with the AKT inhibitor GSK690693. Samples from COVID-19 positive individuals also displayed marked increases in CXCL9, CXCL10, and CXCL11 transcripts as well as transcripts in the AKT pathway. The current study elucidates potential pathway specific targets for reducing the induction of chemokines that may be contributing to SARS-CoV-2 pathogenesis via hyperinflammation.

1 October 2014 in Molecular Biology of the Cell
Verified
Journal Article
Open access
TGTetsuya Gotoh
Tetsuya Gotoh
MVMarian Vila-Caballer
Marian Vila-Caballer
CSCarlo S. Santos
Carlo S. Santos
JLJingjing Liu
Jingjing Liu
JYJianhua Yang
Jianhua Yang
TMTakayoshi Mamine
Takayoshi Mamine
Human Period 2 (hPer2) is a transcriptional regulator at the core of the circadian clock mechanism that is responsible for generating the negative feedback loop that sustains the clock. Its relevance to human disease is underlined by alterations in its function that affect numerous biochemical and physiological processes. When absent, it results in the development of various cancers and an increase in the cell's susceptibility to genotoxic stress. Thus we sought to define a yet-uncharacterized checkpoint node in which circadian components integrate environmental stress signals to the DNA-damage response. We found that hPer2 binds the C-terminal half of human p53 (hp53) and forms a stable trimeric complex with hp53’s negative regulator, Mdm2. We determined that hPer2 binding to hp53 prevents Mdm2 from being ubiquitinated and targeting hp53 by the proteasome. Down-regulation of hPer2 expression directly affects hp53 levels, whereas its overexpression influences both hp53 protein stability and transcription of targeted genes. Overall our findings place hPer2 directly at the heart of the hp53-mediated response by ensuring that basal levels of hp53 are available to precondition the cell when a rapid, hp53-mediated, transcriptional response is needed.

9 November 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TGTetsuya Gotoh
Tetsuya Gotoh
JKJae Kyoung Kim
Jae Kyoung Kim
JLJingjing Liu
Jingjing Liu
MVMarian Vila-Caballer
Marian Vila-Caballer
PSPhilip E. Stauffer
Philip E. Stauffer
CFCarla V. Finkielstein
Carla V. Finkielstein
The circadian clock and cell cycle networks are interlocked on the molecular level, with the core clock loop exerting a multilevel regulatory role over cell cycle components. This is particularly relevant to the circadian factor Period 2 (Per2), which modulates the stability of the tumor suppressor p53 in unstressed cells and transcriptional activity in response to genotoxic stress. Per2 binding prevents Mdm2-mediated ubiquitination of p53 and, therefore, its degradation, and oscillations in the peaks of Per2 and p53 were expected to correspond. However, our findings showed that Per2 and p53 rhythms were significantly out-of-phase relative to each other in cell lysates and in purified cytoplasmic fractions. These seemingly conflicting experimental data motivated the use of a combined theoretical and experimental approach focusing on the role played by Per2 in dictating the phase of p53 oscillations. Systematic modeling of all possible regulatory scenarios predicted that the observed phase relationship between Per2 and p53 could be simulated if (i) p53 was more stable in the nucleus than in the cytoplasm, (ii) Per2 associates to various ubiquitinated forms of p53, and (iii) Per2 mediated p53 nuclear import. These predictions were supported by a sevenfold increase in p53’s half-life in the nucleus and by in vitro binding of Per2 to the various ubiquitinated forms of p53. Last, p53’s nuclear shuttling was significantly favored by ectopic expression of Per2 and reduced because of Per2 down-regulation. Our combined theoretical/mathematical approach reveals how clock regulatory nodes can be inferred from oscillating time course data. Significance Cells sense changes in environmental conditions and translate them into physiological responses that are mediated by a plethora of molecular intermediaries that converge at critical nodes. This is particularly relevant to multiple levels of biological organization in which the circadian clock and cell division are interlocked. Unexpectedly, the circadian rhythms of two critical components of the interlocked system, Period 2 (Per2) and p53, were in antiphase. This finding was analyzed using a systematic modeling approach, and predictions of the model were validated by experimental studies that revealed a distinct and complex scenario. Accordingly, we show that the spatiotemporal organization of Per2:p53 interactions and the nature of their chemical modifications are critical for their time-dependent subcellular redistribution and potential biological functions.